6092 — Enbio Holdings Income Statement

0.000.00%

Last trade - 00:00

IndustrialsBalancedMicro CapNeutral

Annual income statement for Enbio Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,988	8,120	9,576	10,668	12,630
Cost of Revenue
Gross Profit	2,426	2,764	2,484	2,654	3,688
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,855	6,873	8,762	9,829	11,932
Operating Profit	1,133	1,247	813	839	698
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,099	1,233	1,066	702	915
Provision for Income Taxes
Net Income After Taxes	707	795	740	420	252
Minority Interest
Net Income Before Extraordinary Items
Net Income	654	812	709	453	265
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	654	812	709	453	265
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	109	134	90	58.2	108
Dividends per Share